Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FIYY
Barclays ETN+ FI Enhanced Global High Yield ETN Series B
FIYY
|
+$1.49B |
| 2 |
FFEU
Barclays ETN+ FI Enhanced Europe 50 ETN Series C
FFEU
|
+$423M |
| 3 |
SLB Ltd
SLB
|
+$408M |
| 4 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$340M |
| 5 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FIGY
Barclays ETN+ FI Enhanced Global High Yield ETN
FIGY
|
+$1.59B |
| 2 |
FEEU
Barclays ETN+ FI Enhanced Europe 50 ETN
FEEU
|
+$464M |
| 3 |
Citigroup
C
|
+$340M |
| 4 |
American Express
AXP
|
+$206M |
| 5 |
CAA
CalAtlantic Group, Inc.
CAA
|
+$123M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.58% |
| 2 | Technology | 14.9% |
| 3 | Healthcare | 12.05% |
| 4 | Consumer Discretionary | 9.38% |
| 5 | Consumer Staples | 5.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
IPG Photonics
IPGP
$3.7B
| $19.8M | 0.03% |
85,035
-18,128
| -18% | -$4.47M |
|
252
iShares 1-3 Year Treasury Bond ETF
SHY
$25B
| $19.8M | 0.03% |
237,373
+6,688
| +3% | +$559K |
|
253
Omnicell
OMCL
$1.71B
| $19.6M | 0.03% |
450,562
-80,007
| -15% | -$3.68M |
|
|
NTUS
254
DELISTED
Natus Medical Inc
NTUS
| $19.3M | 0.03% |
574,935
-9,894
| -2% | -$313K |
|
255
CVS Health
CVS
$134B
| $18.7M | 0.02% |
300,425
+67,079
| +29% | +$4.81M |
|
256
Honeywell
HON
$78.2B
| $18.3M | 0.02% |
140,472
-3,878
| -3% | -$537K |
|
257
Live Nation Entertainment
LYV
$42.3B
| $17.6M | 0.02% |
418,065
-850
| -0.2% | -$37.7K |
|
258
Align Technology
ALGN
$12.4B
| $17.6M | 0.02% |
70,134
-18,390
| -21% | -$4.72M |
|
259
Medtronic
MDT
$111B
| $17.4M | 0.02% |
216,956
+52,758
| +32% | +$4.35M |
|
|
NUAN
260
DELISTED
Nuance Communications, Inc.
NUAN
| $17.3M | 0.02% |
1,268,683
+146,413
| +13% | +$2.14M |
|
261
Rockwell Automation
ROK
$53.5B
| $17.1M | 0.02% |
98,117
-9,862
| -9% | -$1.87M |
|
262
Fidelity National Information Services
FIS
$23.1B
| $16.4M | 0.02% |
170,187
-16,555
| -9% | -$1.62M |
|
263
D.R. Horton
DHI
$41B
| $16.3M | 0.02% |
371,606
-12,015
| -3% | -$561K |
|
264
Semtech
SMTC
$11.1B
| $16.3M | 0.02% |
416,814
-22,576
| -5% | -$813K |
|
265
Haemonetics
HAE
$3.94B
| $16M | 0.02% |
219,111
-6,528
| -3% | -$448K |
|
266
T. Rowe Price
TROW
$24.2B
| $15.9M | 0.02% |
147,464
+1,537
| +1% | +$171K |
|
267
Extra Space Storage
EXR
$31.6B
| $15.9M | 0.02% |
181,565
-17,628
| -9% | -$1.48M |
|
268
COPT Defense Properties
CDP
$4.26B
| $15.7M | 0.02% |
609,000
-10,750
| -2% | -$285K |
|
269
Globe Life
GL
$14.3B
| $15.4M | 0.02% |
183,270
-2,955
| -2% | -$258K |
|
270
ICU Medical
ICUI
$4.32B
| $15.4M | 0.02% |
61,000
-14,000
| -19% | -$3.29M |
|
271
Altria Group
MO
$114B
| $14.9M | 0.02% |
239,816
+29,056
| +14% | +$1.92M |
|
272
Fair Isaac
FICO
$22.6B
| $14.9M | 0.02% |
87,857
-29,004
| -25% | -$4.84M |
|
273
Post Holdings
POST
$4.09B
| $14.8M | 0.02% |
297,991
+15,028
| +5% | +$760K |
|
|
TPH
274
DELISTED
Tri Pointe Homes
TPH
| $14.6M | 0.02% |
890,775
+38,775
| +5% | +$666K |
|
275
Genpact
G
$5.96B
| $14.5M | 0.02% |
452,654
+21,810
| +5% | +$708K |
|
Similar funds
Ken Fisher's Q1 2018 Portfolio in Review
As of Q1 2018, Ken Fisher held 991 positions worth $75.4B, down 1.5% from $76.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Ken Fisher's Q1 2018 filing shows 69 new, 261 increased, 401 reduced and 162 closed positions. Its largest new stake was Barclays ETN+ FI Enhanced Global High Yield ETN Series B: 15,406,823 shares worth $1.49B. The largest sale was Barclays ETN+ FI Enhanced Global High Yield ETN, an estimated $1.59B.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
- Ken Fisher's largest Q1 2018 buy was Barclays ETN+ FI Enhanced Global High Yield ETN Series B: 15,406,823 shares worth $1.49B.
- Ken Fisher added most to SLB Ltd in Q1 2018, an estimated $408M increase.
- Ken Fisher's biggest Q1 2018 reduction was Barclays ETN+ FI Enhanced Global High Yield ETN, cutting an estimated $1.59B.
- Ken Fisher fully exited CalAtlantic Group, Inc. in Q1 2018, selling an estimated $123M.
- Ken Fisher's ten largest holdings make up 26% of its $75.4B portfolio in Q1 2018.
- Ken Fisher opened 69 new positions and closed 162 in Q1 2018.
- Ken Fisher's portfolio value fell 1.5% quarter-over-quarter to $75.4B.
Based on Fisher Asset Management's 13F filing for Q1 2018, filed 19 Apr 2018.